Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-2259

9 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-2259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Venlafaxine Hydrochloride 150 mg extended-release capsules, bottle count 90, labeled by RemedyRepack Inc. The label includes storage instructions and notes the product is repackaged from Aurobindo Pharma. It also states the product is prescription only and includes a QR code and lot/expiration placeholders.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 01

Venlafaxine HCl 150mg 70518 2259 01
Venlafaxine Hydrochloride Extended-Release 150 mg capsules packaging label, quantity of 90, repackaged by RemedyRepack Inc., Indiana, PA. The label includes the product NDC 70518-2259-01, manufacturer Aurobindo Pharma, Dayton, NJ, storage instructions at 20-25°C, and a notice to keep medication out of children's reach.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 02

Venlafaxine HCl 150mg 70518 2259 02
Label for Venlafaxine Hydrochloride extended-release capsules, 150 mg strength, in a quantity of 30 capsules. The label includes NDC 70518-2259-02, manufacturer information for Aurobindo Pharma, and repackaging details for RemedyRepack Inc. Directions advise storage between 20-25°C, with permitted excursions, and reference to the package insert for use.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 03

Venlafaxine HCl 150mg 70518 2259 03
Venlafaxine Hydrochloride extended-release capsules, 150 mg strength, in a quantity of 30 capsules. The label shows the product name, dosage form, strength, and quantity. It is repackaged by RemedyRepack Inc., with manufacturer information from Aurobindo Pharma, Dayton, NJ. The label includes storage instructions and a note to see the package insert for directions.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 04

Venlafaxine HCl 150mg 70518 2259 04
Venlafaxine Hydrochloride extended-release 150 mg capsules label showing a quantity of 30. The label includes the NDC 70518-2259-04, manufacturer Aurobindo Pharma (Dayton, NJ), and repackager RemedyRepack Inc. Instructions note storage conditions and advise consulting the package insert for directions for use.*
FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
Pharmacokinetic (PK) fold change graph showing the effect of interacting drugs on venlafaxine pharmacokinetics. The chart compares Cmax and AUC values of venlafaxine with various interacting drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, providing recommendations about dose adjustments or cautionary use.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
A pharmacokinetic (PK) fold change chart illustrating interactions between venlafaxine hydrochloride and various drugs. The chart compares the maximum concentration (Cmax) and area under the curve (AUC) of venlafaxine in the presence of interacting drugs like ethanol, diazepam, alprazolam, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Recommendations for dose adjustments or cautions are noted on the right side.*
FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
A chart showing pharmacokinetic changes of venlafaxine in special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender differences. The chart plots fold change and 90% confidence intervals for Cmax, AUC, and ODV compared to reference values, with dosing recommendations such as dose reductions or no adjustments.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride showing its molecular framework including benzene ring, cyclohexane ring, hydroxyl group, and dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.